Amended IN Senate May 17, 2024 Amended IN Senate March 20, 2024 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Bill No. 1468Introduced by Senators Ochoa Bogh and Roth(Coauthors: Senators Becker and McGuire)February 16, 2024An act to add Article 10.8 (commencing with Section 750) to Chapter 1 of Division 2 of the Business and Professions Code, relating to healing arts.LEGISLATIVE COUNSEL'S DIGESTSB 1468, as amended, Ochoa Bogh. Healing arts boards: informational and educational materials for prescribers of narcotics: federal Three Day Rule.Existing law regulates healing arts practitioners by various boards under the Department of Consumer Affairs. Existing federal regulations, known as the Three Day Rule, authorize a practitioner who is not specifically registered to conduct a narcotic treatment program to dispense not more than a 3-day supply of narcotic drugs, in accordance with applicable federal, state, and local laws, to one person or for one persons use at one time for the purpose of initiating maintenance treatment or detoxification treatment while arrangements are being made for referral for treatment, as specified.This bill would require each board that licenses a prescriber, as defined, to develop and biannually annually disseminate to each licensee informational and educational material regarding the Three Day Rule, and to post that material on their internet website. The bill would require the Medical Board of California to also biannually annually disseminate the material it develops to each acute care hospital in the state.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Article 10.8 (commencing with Section 750) is added to Chapter 1 of Division 2 of the Business and Professions Code, to read: Article 10.8. Three Day Rule for Narcotic Drug Prescriptions750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
Amended IN Senate May 17, 2024 Amended IN Senate March 20, 2024 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Bill No. 1468Introduced by Senators Ochoa Bogh and Roth(Coauthors: Senators Becker and McGuire)February 16, 2024An act to add Article 10.8 (commencing with Section 750) to Chapter 1 of Division 2 of the Business and Professions Code, relating to healing arts.LEGISLATIVE COUNSEL'S DIGESTSB 1468, as amended, Ochoa Bogh. Healing arts boards: informational and educational materials for prescribers of narcotics: federal Three Day Rule.Existing law regulates healing arts practitioners by various boards under the Department of Consumer Affairs. Existing federal regulations, known as the Three Day Rule, authorize a practitioner who is not specifically registered to conduct a narcotic treatment program to dispense not more than a 3-day supply of narcotic drugs, in accordance with applicable federal, state, and local laws, to one person or for one persons use at one time for the purpose of initiating maintenance treatment or detoxification treatment while arrangements are being made for referral for treatment, as specified.This bill would require each board that licenses a prescriber, as defined, to develop and biannually annually disseminate to each licensee informational and educational material regarding the Three Day Rule, and to post that material on their internet website. The bill would require the Medical Board of California to also biannually annually disseminate the material it develops to each acute care hospital in the state.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
Amended IN Senate May 17, 2024 Amended IN Senate March 20, 2024
Amended IN Senate May 17, 2024
Amended IN Senate March 20, 2024
CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
Senate Bill
No. 1468
Introduced by Senators Ochoa Bogh and Roth(Coauthors: Senators Becker and McGuire)February 16, 2024
Introduced by Senators Ochoa Bogh and Roth(Coauthors: Senators Becker and McGuire)
February 16, 2024
An act to add Article 10.8 (commencing with Section 750) to Chapter 1 of Division 2 of the Business and Professions Code, relating to healing arts.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
SB 1468, as amended, Ochoa Bogh. Healing arts boards: informational and educational materials for prescribers of narcotics: federal Three Day Rule.
Existing law regulates healing arts practitioners by various boards under the Department of Consumer Affairs. Existing federal regulations, known as the Three Day Rule, authorize a practitioner who is not specifically registered to conduct a narcotic treatment program to dispense not more than a 3-day supply of narcotic drugs, in accordance with applicable federal, state, and local laws, to one person or for one persons use at one time for the purpose of initiating maintenance treatment or detoxification treatment while arrangements are being made for referral for treatment, as specified.This bill would require each board that licenses a prescriber, as defined, to develop and biannually annually disseminate to each licensee informational and educational material regarding the Three Day Rule, and to post that material on their internet website. The bill would require the Medical Board of California to also biannually annually disseminate the material it develops to each acute care hospital in the state.
Existing law regulates healing arts practitioners by various boards under the Department of Consumer Affairs. Existing federal regulations, known as the Three Day Rule, authorize a practitioner who is not specifically registered to conduct a narcotic treatment program to dispense not more than a 3-day supply of narcotic drugs, in accordance with applicable federal, state, and local laws, to one person or for one persons use at one time for the purpose of initiating maintenance treatment or detoxification treatment while arrangements are being made for referral for treatment, as specified.
This bill would require each board that licenses a prescriber, as defined, to develop and biannually annually disseminate to each licensee informational and educational material regarding the Three Day Rule, and to post that material on their internet website. The bill would require the Medical Board of California to also biannually annually disseminate the material it develops to each acute care hospital in the state.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. Article 10.8 (commencing with Section 750) is added to Chapter 1 of Division 2 of the Business and Professions Code, to read: Article 10.8. Three Day Rule for Narcotic Drug Prescriptions750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. Article 10.8 (commencing with Section 750) is added to Chapter 1 of Division 2 of the Business and Professions Code, to read: Article 10.8. Three Day Rule for Narcotic Drug Prescriptions750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
SECTION 1. Article 10.8 (commencing with Section 750) is added to Chapter 1 of Division 2 of the Business and Professions Code, to read:
### SECTION 1.
Article 10.8. Three Day Rule for Narcotic Drug Prescriptions750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
Article 10.8. Three Day Rule for Narcotic Drug Prescriptions750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
Article 10.8. Three Day Rule for Narcotic Drug Prescriptions
Article 10.8. Three Day Rule for Narcotic Drug Prescriptions
750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.(d) The department and boards may consult with other state agencies as necessary to implement this section.
750. (a) For purposes of this section, prescriber means a person authorized to write or issue a prescription pursuant to Section 11150 of the Health and Safety Code.
(b) (1) Each board that licenses a prescriber shall develop informational and educational material regarding the federal Drug Enforcement Administrations Three Day Rule, as codified in subsection (b) of Section 1306.07 of Title 21 of the Code of Federal Regulations, in order to ensure prescriber awareness of existing medication-assisted treatment pathways to serve patients with substance use disorder and shall disseminate the informational and educational material to licensees biannually. disorder.
(2) Each board shall annually disseminate the informational and educational material developed pursuant to paragraph (1) to each licensed prescribers email address on file with the board.
(3) Each board shall post the informational and educational material developed pursuant to paragraph (1) on their internet website.
(c) The Medical Board of California shall also annually disseminate the informational and educational material it develops pursuant to subdivision (b) to each acute care hospital in the state biannually. state. The board may disseminate the informational and educational material to each acute care hospital in the state via email.
(d) The department and boards may consult with other state agencies as necessary to implement this section.